These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9990533)

  • 1. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
    Picard S; Rouet R; Duval D; Chesnay F; Gérard JL
    J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
    Tosaki A; Engelman DT; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KATP channels and 'border zone' arrhythmias: role of the repolarization dispersion between normal and ischaemic ventricular regions.
    Picard S; Rouet R; Ducouret P; Puddu PE; Flais F; Criniti A; Monti F; Gérard JL
    Br J Pharmacol; 1999 Aug; 127(7):1687-95. PubMed ID: 10455327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects against hydrogen peroxide-induced toxicity by activators of the ATP-sensitive potassium channel in isolated rat hearts.
    Gan XT; Cook MA; Moffat MP; Karmazyn M
    J Mol Cell Cardiol; 1998 Jan; 30(1):33-41. PubMed ID: 9500862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
    Tawfik MK; Abo-Elmatty DM; Ahmed AA
    Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
    Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
    Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
    Du Toit EF; Muller CA; McCarthy J; Opie LH
    J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proarrhythmic effects of pinacidil are partially mediated through enhancement of catecholamine release in isolated perfused guinea-pig hearts.
    D'Alonzo AJ; Zhu JL; Darbenzio RB; Dorso CR; Grover GJ
    J Mol Cell Cardiol; 1998 Feb; 30(2):415-23. PubMed ID: 9515018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning.
    Shigematsu S; Sato T; Abe T; Saikawa T; Sakata T; Arita M
    Circulation; 1995 Oct; 92(8):2266-75. PubMed ID: 7554211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Mg++ manipulation prevents the proarrhythmic activity of cromakalim in ischemic/reperfused diabetic hearts.
    Tosaki A; Das DK
    J Pharmacol Exp Ther; 1997 Jul; 282(1):309-17. PubMed ID: 9223569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels.
    Rajesh KG; Sasaguri S; Suzuki R; Xing Y; Maeda H
    Int J Cardiol; 2004 Jul; 96(1):41-9. PubMed ID: 15203260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A; Hellegouarch A
    J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.
    McPherson CD; Pierce GN; Cole WC
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1809-18. PubMed ID: 8238595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Na(+)-K+ pump alleviates the shortening of action potential duration caused by metabolic inhibition via blockade of KATP channels in coronary perfused ventricular muscles of guinea-pigs.
    Abe T; Sato T; Kiyosue T; Saikawa T; Sakata T; Arita M
    J Mol Cell Cardiol; 1999 Mar; 31(3):533-42. PubMed ID: 10198185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K(ATP) channel opening during ischemia: effects on myocardial noradrenaline release and ventricular arrhythmias.
    Remme CA; Schumacher CA; de Jong JW; Fiolet JW; de Groot JR; Coronel R; Wilde AA
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):406-16. PubMed ID: 11486245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.